Patent details

EP2303866 Title: CRYSTALLINE FORMS OF RABEPRAZOLE SODIUM

Basic Information

Publication number:
EP2303866
PCT Application Number:
EP2009057846
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP097799118
PCT Publication Number:
WO2010006904
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
CRYSTALLINE FORMS OF RABEPRAZOLE SODIUM
French Title of Invention:
NOUVELLES FORMES CRISTALLINES DU RABÉPRAZOLE SODIQUE
German Title of Invention:
KRISTALLINE FORMEN VON RABEPRAZOL-NATRIUM
SPC Number:

Dates

Filing date:
23/06/2009
Grant date:
02/08/2017
EP Publication Date:
06/04/2011
PCT Publication Date:
21/01/2010
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
02/08/2017
EP B1 Publication Date:
02/08/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
23/06/2018
Expiration date:
23/06/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
02/08/2017
 
 

Name:
KRKA, tovarna zdravil, d.d., Novo mesto
Address:
Smarjeska cesta 6, 8501 Novo mesto, Slovenia (SI)

Inventor

1

Name:
VRECER, Franc
Address:
Slovenia (SI)

2

Name:
URSKA, Turk
Address:
Slovenia (SI)

3

Name:
ZADNIK, Jernej
Address:
Slovenia (SI)

4

Name:
KOVACIC, Borut
Address:
Slovenia (SI)

5

Name:
KOTAR-JORDAN, Berta
Address:
Slovenia (SI)

Priority

Priority Number:
200800161
Priority Date:
23/06/2008
Priority Country:
Slovenia (SI)

Classification

IPC classification:
A61K 31/4439; C07D 401/12;

Publication

European Patent Bulletin

Issue number:
201731
Publication date:
02/08/2017
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
30/10/2018 Outgoing Correspondence 1